Home › Trial NCT03678649
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
- Trial IDNCT03678649
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorZhejiang Cancer Hospital
- Enrollment180
- Start date2018-09-10
- ConditionsHead and Neck Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.